Jun 4, 2019

Fully electric vehicles could account for 7.6% of U.S. car sales in 2026

The consultancy IHS Markit forecasts that fully electric SUVs of different stripes (especially little ones) are going to start taking off in coming years.

Expand chart
Data: IHS Markit H1 Sales-Based Powertrain Forecast; Chart: Andrew Witherspoon/Axios

Why it matters: Both types of vehicles are hugely popular with U.S. consumers. So the true mainstreaming of EVs, now a tiny market share, will eventually require batteries to power a chunk of this segment.

The big picture: The number of EVs of various types available in the U.S. market is set to mushroom, IHS projects.

  • Overall, they see full EVs accounting for 7.6% of U.S. vehicle sales in 2026.
  • "By 2023, IHS Markit forecasts 43 brands will offer at least one EV option — this will include nearly all existing brands as well as new brands entering the market — compared to 14 brands offering EVs in 2018," they said in a note last week.
  • IHS expects U.S. electric SUV sales to grow to roughly 757,000 units, or nearly 60% of total EV sales, by 2026.

Where it stands: According to the consultancy BloombergNEF, trucks and SUVs account for over 50% of U.S. car sales, but just 19% of the current EV model offerings in the U.S. are SUVs.

Go deeper: American consumers may start looking at electric SUVs in the future

Go deeper

Joe Biden makes first public appearance in over two months

Photo: Oliver Douliery/AFP via Getty Images

Former Vice President Joe Biden made his first in-person appearance in over two months on Monday to honor Memorial Day by laying a wreath at a Delaware veterans park, AP reports.

Why it matters: Biden, the Democratic Party's presumptive nominee, has taken the unprecedented step of campaigning from his home during the coronavirus pandemic, ever since canceling a rally in Cleveland on March 10.

WHO temporarily suspends trial of hydroxychloroquine over safety concerns

Photo: Fabrice Coffrini/AFP via Getty Images

The World Health Organization is temporarily pausing tests of the anti-malarial drug hydroxychloroquine as a coronavirus treatment in order to review safety concerns, the agency's director-general Tedros Adhanom Ghebreyesu said Monday.

Why it matters: The decision comes after a retrospective review published in The Lancet found that coronavirus patients who took hydroxychloroquine or its related drug chloroquine were more likely to die or develop an irregular heart rhythm that can lead to sudden cardiac death, compared to those who did nothing.

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 12 p.m. ET: 5,449,135 — Total deaths: 345,721 — Total recoveries — 2,188,200Map.
  2. U.S.: Total confirmed cases as of 10 a.m. ET: 1,647,741 — Total deaths: 97,811 — Total recoveries: 366,736 — Total tested: 14,163,915Map.
  3. 2020: Trump threatens to move Republican convention from North Carolina.
  4. World: White House announces travel restrictions on Brazil Over 100 cases in Germany tied to single day of church services — Top Boris Johnson aide defends himself after allegations he broke U.K. lockdown
  5. Public health: Officials are urging Americans to wear masks over Memorial Day.
  6. Economy: White House economic adviser Kevin Hassett says it's possible the unemployment rate could still be in double digits by November's election.
  7. What should I do? Hydroxychloroquine questions answeredTraveling, asthma, dishes, disinfectants and being contagiousMasks, lending books and self-isolatingExercise, laundry, what counts as soap — Pets, moving and personal healthAnswers about the virus from Axios expertsWhat to know about social distancingHow to minimize your risk.
  8. Other resources: CDC on how to avoid the virus, what to do if you get it, the right mask to wear.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Updated 2 hours ago - Politics & Policy